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Key messages  
• We established a longitudinal cohort including all migrants resettled in Denmark 
during 23 years to investigate the long-term risk of tuberculosis following immigration 
dependent on specific migrant status and region of origin. 
• We found that the risk of tuberculosis was highest upon receiving residence for all 
migrant groups (year 1: incidence rate 275 per 100,000 person-years; 95% CI 249-
305) followed by only a gradually decline over time. 
• Following resettlement, the tuberculosis risk among migrants remained high for more 
than a decade, particularly among sub-Saharan African migrants, former asylum 
seekers, family-reunified to refugees, and quota refugees.	
• This study underlines the importance of maintaining awareness of tuberculosis risk 
among migrants many years after immigration.  
• Our study suggests that approaches to screening for tuberculosis should be adapted, 
with migrant populations benefiting from long-term and meaningful access to 





Background: Migrants comprise the majority of tuberculosis (TB) in low-incidence 
countries. Only few studies have assessed the long-term TB risk in migrants after 
immigration, and datasets have not considered this across a range of diverse migrant groups. 
This nationwide-study aimed to investigate long-term TB risk among migrants according to 
migrant status and region of origin.  
Methods: Cohort study including all migrants≥18 years who obtained residence in Denmark 
from 1993-2015, with a mean follow-up of 10.8 years (SD 7.3). Migrants were categorised 
based on legal status of residence and region of origin. Incidence rates (IR) and rate ratios 
(IRR) were estimated by Poisson regression. 
Results: 142,314 migrants were included. Across all migrants, the TB risk was highest during 
year one of residence (IR 275/100,000 person-years; 95% CI 249-305) followed by a gradual 
decline, though TB risk remained high for over a decade. Compared to Danish-born, the IRRs 
after 7-8 years were particularly higher among former asylum seekers (IRR 31; 95% CI 20-
46), quota refugees (IRR 31; 95% CI 16-71), and family-reunified to refugees (IRR 22; 95% 
CI 12-44). Sub-Saharan African migrants also experienced elevated risk (IRR 75; 95% CI 51-
109). The proportion of migrants with pulmonary TB was 52.4%. 
Conclusion: All migrant groups experienced an initial high TB risk, but long-term risk 
remained high in key migrant groups. Most European countries focus TB screening on or 
soon after arrival. Our study suggests that approaches to TB screening should be adapted, 
with migrant populations benefiting from long-term access to preventive health services. 
 






Migration is an important factor for tuberculosis (TB) in low-incidence settings, where 
migrants from high-incidence countries often comprise more than 70% of TB cases(1). 
Therefore, improving TB prevention and care among migrants is a key public health priority 
towards TB elimination(2). 
 
The TB risk among migrants is highest within 2-5 years after immigration, but remains high 
for over a decade following migration(3–8). However, migrants are a heterogeneous group 
and some migrants may experience higher TB rates than others. Migrants exposed to high TB 
rates in their country of origin are likely to be at increased TB risk, including several years 
following migration due to reactivation of latent TB infection (LTBI)(9,10). Some migrants, 
for instance refugees, may also be at high risk due to conditions related to migration such as 
overcrowded camps, poor nutrition and stress(11,12). Upon arrival, although many European 
countries have implemented TB screening(13), most of these programmes focus on TB 
among primarily asylum seekers, whereas other newly arrived migrant groups may be 
missed(3,14). After resettling, migrants may experience barriers to health services in the host 
country, which consequently can compromise access to care(15). Lastly, some migrants may 
be exposed to transmission during travels to TB-endemic countries(16).  
 
Only few studies have assessed the long-term TB risk experienced by specific migrant groups 
based on legal grounds for residence following migration to a low-incidence country, since 
most studies have focused on country of origin(17). One study from the UK(3) assessed the 
TB risk among migrants screened before entry, and found that family-reunified migrants had 
the highest risk compared to students, resettlement-refugees and working migrants, but the 
study did not include asylum seekers. 
 
More knowledge on the long-term TB risk among migrants is important in order to inform TB 
elimination strategies. The aim of the present study was to investigate the TB risk among 
migrants who acquired residence in Denmark according to migrant status and region of 
origin. In addition, we assessed the presentation of TB over time (pulmonary versus 
extrapulmonary TB).  
 
Methods 
Design and study population 
This nationwide cohort study included all migrants ≥18 years who obtained residence in 
Denmark between January 1st 1993 and December 31st 2015. Migrants were included in the 
cohort from the date residence was granted. A Danish-born comparison group was identified 
through Statistics Denmark and matched 1:6 on age and sex. The cohort was established in 
2005 and updated in 2016. The construction of the cohort including the matching procedure 
has previously been described in detail(18,19). Individuals with a TB diagnosis in Denmark 







A TB case was defined as all forms of active TB, including pulmonary and extrapulmonary 
TB. Diagnosis was either microbiologically confirmed or based on clinical and/or paraclinical 
findings suggestive of TB prompting TB treatment. Information on how TB cases were 
detected was not available. In Denmark, most TB cases are found based on reporting 
symptoms and few during contact investigations. There was no systematic TB screening 
among migrants during the study period. For the distribution between pulmonary and 
extrapulmonary TB, cases with both pulmonary and extrapulmonary TB were categorized as 
pulmonary TB.  
 
Migrants were grouped according to legal grounds of residence in Denmark, defined as 
migrant status: i) former asylum seekers (in this paper, we refer to asylum seekers granted 
refugee status as former asylum seekers), ii) quota refugees, iii) family-reunified to 
Danish/Nordic citizens, iv) family-reunified to immigrants, and v) family-reunified to 
refugees(20). Migrants were grouped based on region of origin modified from the World 
Bank Group(21): 1) Eastern Europe + Central Asia, 2) Europe, North America + Oceania, 3) 
Latin America + Caribbean, 4) Middle East + North Africa, 5) South-East Asia + Pacific 
(referred to as South-East Asia), and 6) sub-Saharan Africa.  
 
Data generation 
All Danish-born are assigned a unique civil person registration number (CPR) at birth, 
whereas migrants receive a CPR and are registered in the CPR-registry at date of residence 
permission. The CPR can be used to track individuals through public registries at an 
individual level.  
Data on immigration, emigration and death were obtained from Statistics Denmark. In this 
study, year one refers to the first year of receiving residence permission. For quota refugees 
and family-reunified migrants, who are granted residence overseas, this is immediate and 
aligns with day of arrival. For former asylum seekers, who apply for asylum in Denmark, the 
asylum-seeking process can take an average of 6-24 months, but may vary(22). Emigration is 
the date where an individual has given up residence and is deregistered in the CPR-
registry(23). Age, sex, migrant status and country of origin were obtained from The Danish 
Immigration Service. 
Data on culture-verified TB cases were retrieved from the International Reference Laboratory 
of Mycobacteriology, Statens Serum Institut (SSI), where TB diagnostics are centralized. By 
law, TB is a notifiable disease and data on all notified TB cases were retrieved from the 
National Surveillance Register, Department of Infectious Disease Epidemiology and 
Prevention, SSI to ensure we included culture-negative cases.  
 
Data analysis  
Descriptive analyses were carried out using chi-squared and t-test analyses. Poisson 
regression was used to calculate incidence rates (IR) per 100,000 person-years, and incidence 
rate ratios (IRR), both with 95% confidence intervals (CI), using the logarithm of follow-up 
time as offset. Follow-up time was calculated as time from receiving residence until one of 
the following events: i) TB diagnosis, ii) emigration, iii) death, or iv) study-end. 
 
  
Consequently, follow-up time represents duration of residence and quantified the number of 
person-years at TB risk.  
 
IR and IRR were estimated according to duration of residence with one-year intervals. We 
present IR and IRR stratified by migrant status and region of origin using Danish-born as 
reference group. As unadjusted IRR and adjusted IRR showed the same results, table 3 
presents only adjusted IRR. We calculated reduction in risk per year by including duration of 
residence as a continuous variable calculated from the model as (1-exp(change per year on log 
scale))*100 = % reduction per year. We adjusted for age as a time varying covariate in 10-
year intervals.  
 
Results are reported according to STROBE guidelines(24). Analyses were performed in SAS 
version 9.4 (SAS Institute, Cary, NC, USA).  
 
Ethical approval 
This study was approved by the Danish Data Protection Agency (No. 2016-41-4576).  
 
Results 
A total of 142,314 migrants were included in the study with a mean follow-up of 10.8 years 
(SD 7.3) (Supplementary material). The control cohort consisted of 854,820 Danish-born with 
a mean follow-up of 12.4 years (SD 7.1). There were 1841 TB cases among migrants (table 1) 
with the majority of TB cases originating from sub-Saharan Africa (56.4%) and South-East 
Asia (26.2%). There were 398 TB cases among Danish-born. Among migrant TB cases, 
84.5% were ≤40 years at residence date. Among migrants, the mean time from residence to 
TB diagnosis was 4.3 years (SD 4.1).  
 
Among all migrants, the IR was highest in the first year of residence (year 1: IR 275/100,000 
person-years; 95% CI 249-305) followed by a gradual decline over time (year 7-8: IR 
84/100,000 person-years; 95% CI 71-98), corresponding to a decrease of 69% over eight 
years (p<0.05) (table 2).  
 
When stratified by migrant status and region of origin, the IR generally decreased with 
increased time since residence (figure 1 and figure 2). According to migrant status, the IR was 
persistently highest from year one to year 7-8 among former asylum seekers, family-reunified 
to refugees, and quota refugees (table 2). According to region of origin, the IR was 
persistently highest among sub-Saharan African migrants throughout time (year 1: IR 
1373/100.000 person-years; 95% CI 1212-1556, year 7-8: IR 304/100.000 person-years; 95% 
CI 238-389) (table 2). 
 
Compared to Danish-born, the IRR remained higher beyond 13 years of residence among all 
migrant groups (table 3). According to migrant status, the IRR after 7-8 years were 
particularly higher among former asylum seekers (IRR 31; 95% CI 20-46), quota refugees 
(IRR 31; 95% CI 16-71) and family-reunified to refugees (IRR 22; 95% CI 12-44). The 
reduction in risk per year was more pronounced among family-reunified to immigrants 
 
  
(19.7%), family-reunified to refugees (20.7%), and former asylum seekers (15.5%), whereas a 
minor reduction was observed for family-reunified to Danish/Nordic citizens (11.4%) and 
quota refugees (11.5%) (p<0.05).   
According to region of origin, the IRR after 7-8 years were especially higher among migrants 
from sub-Saharan Africa (IRR 75; 95% CI 51-109) and South-East Asia (IRR 31; 95% CI 21-
47). The reduction in risk per year was more pronounced among migrants from sub-Saharan 
Africa (19.7%), whereas a minor reduction was seen among migrants from South-East Asia 
(11.5%), from the Middle East and North Africa (14.2%), and from Eastern Europe and 
Central Asia (9.9%).  
 
Overall, among Danish-born TB cases, a greater proportion were pulmonary TB (87.4%) than 
among migrants (52.6%) (p<0.05). This distribution did not change over time (figure 3).  
 
Discussion 
The findings show that the TB risk among migrants remains high for over a decade of 
residence with only a gradual decline in risk over time. TB risk was found to be associated 
with migrant status and region of origin. The highest risk both initially and long-term was 
observed among former asylum seekers, family-reunified to refugees and quota refugees, and 
migrants from sub-Saharan Africa, whereas family-reunified to immigrants and family-
reunified to Danish/Nordic citizens had lower risk.  
 
Overall, our findings are similar to previous studies reporting a high TB incidence soon after 
immigration as well as many years after(5–8). The initial IR in our migrant population was 
275/100,000 person-years (95% CI 249-305) decreasing to 84/100,000 person-years (95% CI 
71-98) over eight years. This was slightly higher than the IR among refugees, asylum seekers 
and persons migrating for work in Norway, decreasing from 210/100,000 person-years (95% 
CI 190-230) to 50/100,000 person-years (95% CI 30-70) over seven years(6). This study did 
not stratify by migrant status. The gradual decrease seen in our study was unlike the sharp 
decline from the first to the second year in the Norwegian study. First, this could be explained 
by the lack of arrival screening in our cohort. In Norway, mandatory radiographic TB 
screening is performed upon arrival for all refugees and for migrants from high-incidence TB 
countries. Thus, the drop in incidence from the first to the second year in Norway could likely 
be explained by a high TB detection rate during the screening process, in contrast to our study 
population without systematic TB screening. In Denmark, asylum seekers were offered a 
voluntary general health assessment on arrival, but this did not include systematic TB 
screening before 2017. Quota refugees and family-reunified migrants were not offered health 
assessment or TB screening(20). Prior to arrival in Denmark, only quota refugees are required 
to attend TB screening, but these data or data on TB/LTBI treatment were not available. 
Second, migrants from high-incidence TB countries aged 15-35 years were screened for LTBI 
upon arrival in Norway. If they were treated for LTBI (not reported), this would lower the risk 
of reactivation also partly explaining the sharp decline(25). A lower risk was also seen in a 
study among immigrants (not further specified) and refugees who were granted permanent 
residence in Canada: The IR was 63/100,000 person-years in the first two years after arrival 
decreasing to 14/100,000 person-years in years 11-16(8). The lower IR upon arrival may be 
 
  
because migrants in Canada must undergo radiographic TB screening overseas before being 
granted residence, and those with active TB are treated before arrival. The Canadian study 
identified the highest risk-group as migrants from countries with IR ≥100/100,000 person-
years, but did not stratify by migrant status.  
 
The proportion of migrants recently infected either in the country of origin or during 
migration is likely to contribute to the high risk in the early years after migration, as the risk 
of reactivating LTBI is highest within the first 2-5 years after infection(10). Former asylum 
seekers, quota refugees, and family-reunified to refugees had the highest TB risk after one 
year since residence was granted. Former asylum seekers and family-reunified to refugees 
also had a steeper reduction in risk compared to family-reunified to Danish/Nordic citizens. 
Soon after immigration, former asylum seekers and family-reunified to refugees might be a 
high-risk group compared to other migrant groups due to the potential high risk of TB 
transmission during migration. Typically, asylum seekers leave their home under critical 
circumstances, spend time in overcrowded camps or travel in perilous conditions favouring 
TB transmission(11). Although family-reunified to refugees migrate under different legal 
terms than asylum seekers, they are also likely to be highly vulnerable to TB since they are 
often fleeing under just as critical circumstances(15). Additionally, the high rates could also 
reflect risk factors favouring LTBI reactivation such as stress or poor nutrition(26).  
 
The high TB rates according to region of origin are consistent with previous studies where 
migrants from TB-endemic countries have an increased risk following migration, largely 
driven by LTBI reactivation(3,5,9). In our population, the risk after eight years of residence 
was still 75 and 32 times higher among sub-Saharan African and South-East Asian migrants, 
respectively, compared to Danish-born. One important aspect is that the majority of TB cases 
among former asylum seekers (71.4%) and family-reunified to refugees (75.4%) were from 
sub-Saharan Africa, largely contributing to the high IR observed in these migrant groups. E.g. 
the total IR among former asylum seekers and family-reunified to refugees were 156 (95% CI 
146-167) and 199 (95% CI 179-221), respectively, whereas the total IR among sub-Saharan 
African former asylum seekers and family-reunified to refugees were 790 (95% CI 732-853) 
and 707 (95% CI 624-801), respectively(20). Even though originating from a TB-endemic 
region is a highly important risk factor, migrant status may contribute to the TB risk through 
other well-known TB risk factors during migration such as impaired living conditions, 
malnutrition etc.(27). For instance, 60.3% of South-East Asian migrants were family-
reunified to Danish/Nordic citizens, and are likely to have arrived directly from their country 
of origin, travelled under less stressful means, and arrived within a support system. However, 
differences may also reflect differences in socio-economic status in the country of origin.  
 
After resettlement, migrants might acquire new infections through TB transmission in the host 
country or during travels to TB high-risk areas. Studies indicate a low degree of transmission 
between migrants and the host-population in low-incidence countries(28). Family-reunified to 
Danish/Nordic citizens may have a higher level of travels to their country of origin than 
family-reunified to refugees and former asylum seekers, whose countries of origin may be in 
unstable conditions, however whether travel is a risk factor was not explored in this study.  
 
  
The high TB proportion among migrants ≤40 years at residence partly reflects the overall age 
distribution in our migrant cohort, with mostly younger people migrating to Denmark. The 
total TB risk was lower among migrants ≤40 years than migrants ≥65 years, but there was no 
difference when stratified according to duration of residence, possibly due to the low TB 
numbers among migrants ≥65 years (n=61). This was unlike the Canadian study, where 
migrants ≥65 years at arrival maintained a higher risk than younger migrants throughout post-
migration(8). The higher risk with ageing possibly reflects increased LTBI reactivation from 
risk factors and comorbidities increasing with age(29,30).  
 
The high proportion of extrapulmonary TB among migrants is consistent with previous 
studies(31,32), and attributed to the large proportion of Somali migrants with extrapulmonary 
TB in our cohort(33). We did not observe changes in the distribution between pulmonary and 
extrapulmonary TB over time. This is in contrast to the Norwegian study(6), where the higher 
proportion of pulmonary TB during the first year probably was due to CXR screening upon 
arrival. From a public health perspective, extrapulmonary TB is less important for the TB 
transmission, but extrapulmonary TB is often attributed to reactivation(34) which emphasizes 
the need to consider LTBI screening among migrants. 
 
Strengthening screening for active TB at arrival can potentially reduce the high TB risk 
following immigration, particularly among migrants at highest risk i.e. migrants from sub-
Saharan Africa, family-reunified to refugees, former asylum seekers and quota refugees. 
However, given the long-term TB risk related to reactivation of LTBI(3,10), LTBI screening 
and treatment could be important tools to reduce subsequent reactivation among the high-risk 
groups(35–37). Recently in the UK(37), pre-entry screening for active TB among migrants 
combined with post-entry LTBI screening and treatment was associated with a decrease in 
incidence following resettlement. As LTBI treatment is effective and short-term regimes of 
only month rifapentine and isoniazid become increasingly available(38,39), we may come 
closer towards TB elimination. However, strategies to increase follow-up and treatment 
completion are crucial for LTBI screening programmes to be effective(25,40). Furthermore, 
as many TB cases develop years after arrival, long-term access to preventive healthcare 
should be prioritized so TB signs of can be spotted and diagnostics initiated. 
 
Strengths and limitations 
Major strengths of this study were the large cohort size and duration of follow-up. Utilizing 
the unique Danish CPR registry, we could identify and follow all migrants who received 
residence in the study period on a nationwide, individual level with high-quality data on TB, 
emigration and mortality. This enabled us to estimate the TB risk for over a decade. We 
believe our data reflect the long-term TB risk among migrants following resettlement in a 
low-incidence country. Still, there were limitations. Some migrants (n=191) were diagnosed 
with TB in Denmark between arrival and obtaining residence. Large uncertainties were 
associated with information on specific arrival date and were not available for all migrants. 
We therefore based inclusion on residence date as the CPR is assigned here allowing for exact 
follow-up through registries. A consequence of this approach is an underestimation of TB on 
arrival in our migrant population, particularly among former asylum seekers. Second, 
 
  
migrants <18 years were not included. Children were received differently at arrival in 
Denmark with regards to social support and health assessment, thus to minimize potential bias 
only adults were included. 
 
Conclusion 
Following immigration, the TB risk remained high for more than a decade, particularly 
among sub-Saharan African migrants, former asylum seekers, family-reunified to refugees, 
and quota refugees. Most European countries focus on TB screening upon arrival. Our study 
underlines the importance of maintaining awareness of TB risk among migrants many years 
after immigration, and suggests that approaches to TB screening should be strengthened and 
adapted with migrant populations benefiting from long-term access to preventive health 
services, including LTBI screening.  
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TABLE 1 Baseline characteristics among tuberculosis cases1 by migrant status (n = 2239) 
 
 












Sex        
  Female 39.2 (156)* 53,3 (982)* 42.8 (395)* 25.6 (32)* 71.5 (266)* 52.2 (48) 73.2 (241)* 
  Male 60.8 (242) 46,7 (859) 57.2 (528) 74.4 (93) 28.5 (106) 47.8 (44) 26.8 (88) 
Age at residency2        
  ≤ 40 years 76.4 (304) 84.5 (1555) 82.3 (760) 88.0 (101) 90.3 (336) 85.9 (79) 84,8 (279) 
  41-64 years 22.4 (89) 12.2 (225) 13.1 (121) 17.6 (22) 8.8 (33) 13.0 (12) 11.3 (37) 
  ≥ 65 years 1.3 (5) 3.3 (61) 4.6 (42) 1.6 (2) 0.8 (3) 1.1 (1) 4.0 (13) 
Time to diagnosis, years3 8.8 (5.6) 4.3 (4.1) 4.3 (4.2)  4.3 (3.8) 4.6 (4.1) 4.4 (4.2) 3.9 (3.9) 
Age at diagnosis, years4 41.1 (33.6-49.3) 32.9 (27.8-40.2) 33.1 (27.8-40.9) 33.7 (26.8-41.6) 33.1 (28.9-38.5) 30.9 (25.6-38.6) 32.1 (27.5-39.5) 
Region of origin        
  Eastern Europe + Central 
Asia 
  N/A 10.7 (197) 14.6 (135)  0 (0) 7.0 (26) 34.8 (32) 1.2 (4) 
  Latin America + Caribbean  N/A 0.3 (6) 0.1 (1) 0 (0) 1.3 (5) 0 (0) 0 (0) 
  Europe, North America + 
Oceania 
N/A 0.8 (15) 0.2 (2) 0 (0) 2.4 (9) 2.2 (2) 0.6 (2) 
  Middle East + North Africa N/A 5.5 (102) 5.5 (51) 10.4 (13)  3.5 (13) 7.6 (7) 5.5 (18) 
  South-East Asia  N/A 26.2 (483) 8.1 (75) 51.2 (64) 66.1 (246) 44.6 (41) 17.3 (57) 
  Sub-Saharan Africa  56.4 (1038) 71.4 (659) 38.4 (48) 19.6 (73) 10.9 (10) 75.4 (248) 
Country of origin5        
  Afghanistan N/A 4.7 (86) 6.2 (57) 3.2 (4) 0.3 (1) 0 (0) 7.3 (24) 
  Former Yugoslavia N/A 7.5 (138) 12.2 (113) 0 (0) 2.4 (9) 13.0 (12)  1.2 (4) 
  Pakistan N/A 3.7 (69) 0.1 (1) 0 (0) 12.9 (48) 18.5 (17) 0.9 (3) 
  Somalia N/A 47.1 (873) 66.9 (617) 9.6 (12) 1.3 (5) 5.4 (5) 71.1 (234) 
  Thailand N/A 4.6 (85)   0 (0) 0 (0) 21.2 (79) 6.5 (6) 0 (0) 
Data are presented as % (n) unless otherwise stated. 1. All forms of active tuberculosis. 2. For Danish-born age at inclusion. 3. Mean (standard deviation). 4. Median 
(interquartile range). 5. Five most frequent countries of origins among tuberculosis cases. *p<0.01 for the difference between sex.  
	
TABLE 2 Incidence rates of tuberculosis1 according to duration of residency among migrants by migrant status and region of origin2 
compared to Danish-born (n = 997,134) 
 Duration of residency 
 1 year 2 years 3-4 years 5-6 years 7-8 years 9-12 years + 13 years 
 IR/100,000 person-years (95% CI) 
Danish-born 3 (2-4) 4 (3-6) 4 (3-5) 3 (2-4) 4 (3-5) 4 (3-4) 4 (4-5) 
Migrants  275 (249-305) 253 (226-282) 209 (190-229) 135 (120-152) 84 (71-98) 56 (48-65) 33 (28-39) 
  Former asylum seekers 416 (363-476)  344 (292-404) 282 (247-323) 177 (148-211) 121 (97-151) 77 (63-94) 37 (29-47) 
  Quota refugees 333 (212-521) 386 (252-592) 275 (190-399) 315 (219-453) 137 (76-248) 95 (54-167) 36 (14-86) 
  Family-reunified to        
   - Danish/Nordic citizens  129 (102-162) 105 (80-137) 96 (78-118) 69 (53-90) 52 (37-71) 36 (27-49) 22 (15-32) 
   - immigrants 220 (143-337)  165 (99-273) 122 (80-188) 87 (51-147) 34 (14-81) 27 (13-56) 24 (13-46) 
   - refugees 375 (286-490) 552 (437-698) 452 (372-548) 209 (155-280) 91 (57-144) 53 (34-83) 57 (38-87) 
        
Region of origin        
  Eastern Europe + Central Asia 62 (40-95) 61 (40-95) 71 (53-95) 59 (43-83) 43 (29-64) 24 (16-35) 19 (13-28) 
  Middle East + North Africa 67 (44-101) 75 (48-116) 40 (25-63 27 (15-49) 24 (29-64) 20 (11-34) 12 (6-23) 
  South-East Asia  258 (207-321) 243 (193-307) 219 (183-263) 182 (147-226) 123 (92-163) 84 (64-110) 48 (34-68) 
  Sub-Saharan Africa 1374 (1213-1557) 1282 (1114-1476) 1048 (932-1180) 558 (470-663) 304 (238-389) 216 (173-271) 126 (97-165) 
IR: Incidence rates; CI: Confidence interval; 1. All forms of active tuberculosis. 2. Latin America + Caribbean, and Europe, North America + Oceania region of origin are not 



























TABLE 3 Incidence rate ratios of tuberculosis1 according to duration of residence among migrants by migrant status and region of origin2 
compared to Danish-born (n = 997,134) 
 Duration of residency  
 1 year 2 years 3-4 years 5-6 years 7-8 years 9-12 years + 13 years Reduction/
year3 
 IRR4 (95% CI)  	 	 	 	 	 % per year	
         
Danish-born5,6 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 
Migrants  99 (58-167) 62 (39-99) 57 (38-86) 47 (29-76) 20 (13-32) 15 (10-24) 7 (5-10) 15.5 
  Former asylum seekers 153 (100-237) 87 (59-129) 79 (56-112) 63 (42-96) 31 (20-46) 21 (15-31) 8 (5-11) 15.5 
  Quota refugees 121 (65-223)  96 (55-169) 76 (45-128)  110 (64-191) 34 (16-71) 26 (13-53) 7 (2-21) 11.5 
  Family-reunified to         
   - Danish/Nordic citizens  46 (28-73) 26 (16-40) 26 (18-38) 24 (15-38) 13 (7-20) 10 (7-16) 5 (3-9) 11.4 
   - immigrants 75 (41-136) 38 (21-72) 32 (18-56) 28 (14-57) 8 (3-22) 7 (3-17) 6 (3-13) 19.7 
   - refugees 133 (81-218) 134 (87-206) 121 (83-177) 71 (44-117) 22 (12-44) 15 (8-27) 16 (9-27) 20.7 
         
Region of origin         
  Denmark5,6 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 
  Eastern Europe + Central 
Asia 
22 (12-39) 15 (8-26) 19 (12-28) 20 (12-32) 10 (6-17) 6 (4-10) 4 (3-6) 9.9 
  Middle East + North Africa 23 (13-42)  18 (10-32) 11 (6-18) 9 (5-19) 6 (3-12) 5 (3-10) 3 (1-6) 13.2 
  South-East Asia  95 (60-151) 61 (40-93) 62 (44-86) 65 (44-97) 31 (21-47) 24 (17-35) 12 (8-18) 11.5 
  Sub-Saharan Africa 488 (305-779) 313 (207-475) 284 (209-386) 194 (134-282) 75 (51-109) 61 (43-86) 29 (21-40) 19.7 
IRR: Incidence rate ratios; CI: Confidence interval; 1. All forms of active tuberculosis. 2. Latin America and Europe, North America + Oceania region of origin are not included 
for analysis due to insufficient power. 3. Reduction in TB risk per year e.g. (1-exp(slope coefficient))*100 =  (1-exp(-0.1686))*100 = 15.5% reduction per year. 4. Adjusted for 
































Years of residence 
  Migrants total 
  Asylum seekers  
  Quota refugees 
  Family-reunified to Danish/
Nordic citizens 
  Family-reunified to 
immigrants 
  Family-reunified to refugees 
  Danish-born 
+ 
TB cases         373            307            263             191            153             112             81              67               56              46               32              35              124 
Population   142,314    127,532      116,573      108,462     102,993       98,470       93,116       88,489        84,333       79,775        75,894       72,363        69,013                          
Migrants per year, n 
PYR: Person-years 
FIGURE 1 Tuberculosis incidence rates by years of residence among migrants 


























Years of residence 
  Eastern Europe + Central Asia 
  Middle East + North Africa 
  South-East Asia and Pacific 
  Sub-Saharan Africa 
  Danish-born 
+ 
TB cases         373            307            263             191            153             112             81              67               56              46               32              35              124 
Population   142,314    127,532      116,573      108,462     102,993       98,470       93,116       88,489        84,333       79,775        75,894       72,363        69,013                          
Migrants per year, n 
PYR: Person-years 
FIGURE 2 Tuberculosis incidence rates by years of residence among migrants 
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FIGURE 3 Proportion of pulmonary tuberculosis by years of residence among 
migrants and Danish-born, Denmark, 1993-2015 (n = 997,134)  
